In TUXEDO-2, ticagrelor failed to meet the bar for noninferiority, with most outcomes hinting at an advantage for prasugrel.
Bose sent this for free, but the views are my own, and I genuinely see this as a massive improvement over their previous micro** Chapters 0:00 intro 0:26 specs 0:47 much better than 1st gen 2:08 music ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback